Increased HDAC4 expression in androgen-independent cell lines suggests a role in prostate cancer progression and therapeutic resistanceHigher HDAC5 expression in recurrent prostate cancer suggests a role in disease progression. This evidence concerns the gene HDAC5 and prostate cancer.